These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3001292)

  • 41. In vitro studies on the absorption of WR-2721 by tumors and normal tissues.
    Ritter MA; Brown DQ; Glover DJ; Yuhas JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):523-6. PubMed ID: 6286546
    [No Abstract]   [Full Text] [Related]  

  • 42. [Efficacy of protective effect of aminopropylamino-ethylthiophosphate in neutron beam, gamma or X-irradiation of mice (author's transl)].
    Sedlmeier H; Metzger E; Jentzsch U; Weitzenegger E
    Strahlentherapie; 1981 Oct; 157(10):685-91. PubMed ID: 6272452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1H NMR pattern recognition and 31P NMR studies with d-Serine in rat urine and kidney, time- and dose-related metabolic effects.
    Williams RE; Jacobsen M; Lock EA
    Chem Res Toxicol; 2003 Oct; 16(10):1207-16. PubMed ID: 14565762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The modification of melphalan toxicity in tumor bearing mice by s-2-(3-aminopropylamino)- ethylphosphorothioic acid (WR 2721).
    Millar JL; McElwain TJ; Clutterbuck RD; Wist EA
    Am J Clin Oncol; 1982 Jun; 5(3):321-8. PubMed ID: 6282111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radioprotective and toxic effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721) on the development of immunocompetent cells.
    Yuhas JM
    Cell Immunol; 1972 Jul; 4(3):256-63. PubMed ID: 5064475
    [No Abstract]   [Full Text] [Related]  

  • 46. Toxicity studies on the radioprotective agent WR-2721 in CDF1 mice and beagle dogs.
    Palmer TE; Glaza SM; Dickie BC; Weltman RH; Greenspun KS
    Toxicol Pathol; 1985; 13(1):58-65. PubMed ID: 2994205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measurement of tissue oxidation-reduction state with carbon-13 nuclear magnetic resonance spectroscopy.
    Livesey JC; Golden RN; Shankland EG; Grunbaum Z; Richards TL; Wade RA; Krohn KA
    Cancer Res; 1989 Apr; 49(8):1937-40. PubMed ID: 2539249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Possible association of radioprotective and chemoprotective aminophosphorothioate drug activity with polyamine oxidase susceptibility.
    Gaugas JM
    J Natl Cancer Inst; 1982 Aug; 69(2):329-32. PubMed ID: 6287074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uptake of WR-2721 derivatives by cells in culture: identification of the transported form of the drug.
    Calabro-Jones PM; Aguilera JA; Ward JF; Smoluk GD; Fahey RC
    Cancer Res; 1988 Jul; 48(13):3634-40. PubMed ID: 2837319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein binding of N-2-mercaptoethyl-1,3-diaminopropane via mixed disulfide formation after oral administration of WR 2721.
    Tabachnik NF; Blackburn P; Peterson CM; Cerami A
    J Pharmacol Exp Ther; 1982 Feb; 220(2):243-6. PubMed ID: 6276531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circumvention of the tumor membrane barrier to WR-2721 absorption by reduction of drug hydrophilicity.
    Yuhas JM; Davis ME; Glover D; Brown DQ; Ritter M
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):519-22. PubMed ID: 6286545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography.
    Souid AK; Newton GL; Dubowy RL; Fahey RC; Bernstein ML
    Cancer Chemother Pharmacol; 1998; 42(5):400-6. PubMed ID: 9771955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An improved HPLC assay for S-2-(3-aminopropylamino)ethyl phosphorothioate (WR-2721) in plasma.
    Swynnerton NF; McGovern EP; Niño JA; Mangold DJ
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1521-4. PubMed ID: 6090354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Depletion of glutathione by the radioprotective agent S-2-(3-aminopropylamino)ethyl phosphorothioic acid (WR2721).
    Schor NF
    Biochem Pharmacol; 1988 Feb; 37(3):562-3. PubMed ID: 2827689
    [No Abstract]   [Full Text] [Related]  

  • 55. WR-2721: enhanced chemoprotection by increasing cyclophosphamide activation with phenobarbitol.
    Glover DJ; Yuhas JM; Glick JH
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):571-4. PubMed ID: 6286555
    [No Abstract]   [Full Text] [Related]  

  • 56. A method for the combined measurement of ethiofos and WR-1065 in plasma: application to pharmacokinetic experiments with ethiofos and its metabolites.
    Swynnerton NF; Huelle BK; Mangold DJ; Ludden TM
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1495-9. PubMed ID: 3019967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isotachophoretic determination of phosphate splitting from Amifostine and p-nitrophenyl phosphate in serum and neuroblastoma cells.
    Renner S; Klingebiel T; Niethammer D; Bruchelt G; Meissner T; Eisenbeiss F
    J Chromatogr A; 1999 Apr; 838(1-2):251-7. PubMed ID: 10327642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thin layer chromatographic and colorimetric methods for monitoring the purity of S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR-2721).
    Washburn LC; Hayes RL
    Anal Chem; 1974 Dec; 46(14):2231-2. PubMed ID: 4440864
    [No Abstract]   [Full Text] [Related]  

  • 59. NMR studies of drug metabolism and disposition.
    Bell JD; Gadian DG; Preece NE
    Eur J Drug Metab Pharmacokinet; 1990; 15(2):127-33. PubMed ID: 2200682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo dephosphorylation of WR-2721 monitored by 31P NMR spectroscopy.
    Knizner SA; Jacobs AJ; Lyon RC; Swenberg CE
    J Pharmacol Exp Ther; 1986 Jan; 236(1):37-40. PubMed ID: 3001292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.